MMRF CoMMpass StudySM Updates

August 21, 2019 10:00 am to 11:15 am
Join Us on Wednesday, August 21:

MMRF CoMMpass StudySM Updates
1:00 - 2:00 PM (EDT)

Register Today


Dear Robert,

Both assessment of disease risk and treatment decisions for multiple myeloma can now be personalized to each patient based on the patient’s genetics, and the MMRF's CoMMpass Study has proven key to furthering the research that has led to these advances.

Join us on August 21 for this FREE webinar and learn more about this pivotal study, in which more than 1,100 patients with newly diagnosed active myeloma are being tracked over a period of eight years. Myeloma experts from around the country will share the important discoveries that have emerged from the CoMMpass Study and what they could mean for myeloma patients.

Presenting Faculty:

Faith E. Davies, MBBCh, MD
NYU Langone Health
New York, NY


Jonathan Keats, PhD
Translational Genomics
Research Institute (TGEN)
Phoenix, AZ

Sagar Lonial, MD
Emory University
Atlanta, GA
Register Today